Besides, there was no significant difference in GPR17 expression between NPC tumor tissues and control samples in clinical samples, indicating that the effect of GPR17 on NPC development depended on receptor activation (Figure S5C, Supporting Information). This evidence concerns the gene GPR17 and neoplasm.